Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

This study has been completed.
Information provided by:
Boehringer Ingelheim Identifier:
First received: September 11, 2006
Last updated: October 30, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: July 2007 (Final data collection date for primary outcome measure)